Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Essure maker, Gynecare terminate agreement
September 8th, 2005
Conceptus, Inc., (CPTS), developer of the Essure nonincisional permanent birth control system, announced that effective immediately, Conceptus and Gynecare Worldwide, a division of Ethicon, Inc., have mutually agreed to terminate the exclusive copromotion agreement entered into by the companies on October 30, 2003. Both companies believe the relationship has been instrumental in educating physicians about the safety and efficacy of the concomitant use of the Essure device and the GYNECARE THERMACHOICE Uterine Balloon Therapy System. Building upon the accomplishments to date, the termination includes agreement to continue working together on an informal basis at future...
Source: Women's Health Weekly (2005-09-08)
|
